US provides Ebola treatment for outbreak in Congo, bringing trials closer
The US has pledged $267 million in additional Ebola assistance for the Democratic Republic of Congo. The Ebola outbreak has claimed 3,901 lives out of 8,000 confirmed cases. The US support includes treatment units and expanded surveillance. The World Health Organization is calling for accelerated diagnosis, faster referrals, and specialized care to protect high-risk groups, particularly children under five years old.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ The number of confirmed Ebola cases in the Democratic Republic of Congo has surpassed 8,000.
- ✓ 3,901 people have died in the current Ebola outbreak in the Democratic Republic of Congo.
- ✓ The US has pledged an additional $267 million for life-saving assistance against Ebola in Congo.
- ✓ Children under five years old are experiencing a disproportionate number of deaths during the Bundibugyo virus outbreak in the Democratic Republic of Congo.
What changed
The US has announced an additional $267 million in Ebola assistance for the Democratic Republic of Congo, bolstering its previous commitments.
Live updates
-
US provides Ebola treatment for outbreak in Congo, bringing trials closer
The US has pledged $267 million in additional Ebola assistance for the Democratic Republic of Congo. The Ebola outbreak has claimed 3,901 lives out of 8,000 confirmed cases. The US support includes treatment units and expanded surveillance. The World Health Organization is calling for accelerated diagnosis, faster referrals, and specialized care to protect high-risk groups, particularly children under five years old.
Why it matters
The Ebola outbreak in the Democratic Republic of Congo continues to pose a significant health risk. The World Health Organization has emphasized the need for pediatric-specific interventions to reduce mortality rates among children. The US support aims to bolster the response efforts and bring clinical trials of Ebola treatments closer to reality.
What is confirmed
- The number of confirmed Ebola cases in the Democratic Republic of Congo has surpassed 8,000.
- 3,901 people have died in the current Ebola outbreak in the Democratic Republic of Congo.
- The US has pledged an additional $267 million for life-saving assistance against Ebola in Congo.
- Children under five years old are experiencing a disproportionate number of deaths during the Bundibugyo virus outbreak in the Democratic Republic of Congo.
What to watch next
- Further international commitments to support Ebola response efforts
- Progress in clinical trials of Ebola treatments
- Development of pediatric-specific interventions to reduce mortality rates among children
confidence 100%Sources used for this update (7)
- jen.jiji.com — Nor’easter threatens US East Coast as Tropical Storm Nolo nears Hawaii
- jen.jiji.com — Kazakhstan’s Kholmogorov takes 2026 Asian Games canoe sprint bronze
- www.breitbart.com — vaccines Articles - Breitbart
- www.africanews.com — Ebola cases in DR Congo cross 8,000 as EU, US pledge further ...
- globebanner.com — United States announces $267 million in additional Ebola ...
- www.cdc.gov — Notes from the Field: The First 100 Days of Five Ebola ...
- cmsapi.theepochtimes.com — US Pledges $267 Million More in Ebola Aid to Congo
-
WHO warns children under five are most vulnerable in DRC Ebola outbreak
Children under five years old are experiencing a disproportionate number of deaths during the Bundibugyo virus outbreak in the Democratic Republic of Congo. The World Health Organization is calling for accelerated diagnosis, faster referrals, and the implementation of specialized care to protect this high-risk group. While previous reports focused on US treatment provisions and trial progress, current warnings emphasize the critical need for pediatric-specific interventions to reduce mortality rates among the youngest victims of the outbreak.
Why it matters
The Bundibugyo virus is a species of Ebola that causes severe hemorrhagic fever. Rapid identification and specialized medical support are essential to prevent widespread fatalities in vulnerable populations.
Still unconfirmed
- Children under five are bearing a disproportionate share of deaths in the DRC's Bundibugyo virus outbreak
What to watch next
- WHO reports on the impact of faster diagnosis and specialized care for children
confidence 70%Sources used for this update (5)
- jen.jiji.com — M5.4 earthquake strikes southeastern Türkiye
- jen.jiji.com — How Astana Airport is winning battle against bird strikes
- www.standardmedia.co.ke — Ebola Watch: WHO warns children under five face higher risk in DRC Ebola outbreak
- www.devdiscourse.com — Reuters Health News Summary
- eastleighvoice.co.ke — Nearly 1 in 6 children on weight-loss injections developed nutritional problems- study
-
UK Scientists Identify Genetic Changes in Kent Meningitis Outbreak
British researchers have identified genetic changes behind a severe meningococcal disease outbreak in Kent that struck 21 people in a single week. Scientists from the UK Health Security Agency, the University of Oxford, and academic partners sequenced bacteria from the March outbreak linked to a Canterbury nightclub. Research presented at the UKHSA Conference 2026 shows the strain acquired genetic material from less harmful throat bacteria via horizontal gene transfer. The cluster required hospital treatment for all diagnosed individuals, nine intensive care admissions, and resulted in two deaths.
Why it matters
The investigation into the Kent outbreak highlights the speed of genomic sequencing during public health crises, as researchers mapped the bacteria days after the initial case. Meningococcal disease remains a severe health threat, requiring rapid identification of genetic shifts that alter virulence. This genetic analysis contributes to ongoing global discussions on health security and pandemic preparedness featured at international forums.
What is confirmed
- Scientists from the UK Health Security Agency, the University of Oxford and academic partners identified genetic changes behind a meningococcal disease outbreak in Kent.
- The outbreak was linked to a single nightclub in Canterbury over one weekend in March and resulted in 21 diagnoses within one week.
- All 21 patients required hospital treatment, nine were admitted to intensive care and two died.
- UKHSA scientists sequenced the outbreak bacteria within days of the first case and compared them with tens of thousands of meningococcal genomes.
- Research presented at the UKHSA Conference 2026 found the outbreak strain acquired genetic material from less harmful bacteria naturally found in human throats through horizontal gene transfer.
What to watch next
- Further peer-reviewed publication of the preprint research presented at the UKHSA Conference 2026
- Additional findings on how horizontal gene transfer impacts future meningococcal vaccine development
confidence 100%Sources used for this update (3)
- jen.jiji.com — Scientists reveal genetic changes behind severe Kent meningitis outbreak
- foreignpolicy.com — Health Forum @ UNGA81
- jen.jiji.com — Tokayev nominates Yerlan Koshanov to head Khalyk Kenesi
-
Vaccine tests launch in Democratic Republic of Congo Ebola outbreak zone
Health workers launched a test vaccination program on Saturday in areas of the Democratic Republic of Congo most affected by the current Ebola outbreak. This follows previous medical interventions including the distribution of 16,000 Ervebo vaccine doses from Merck and treatment support provided by the United States. The effort aims to curb a crisis that has seen confirmed cases exceed 6,100 and deaths surpass 3,000, with a crude fatality rate of 48%.
Why it matters
The outbreak continues to expand across the region. NanoViricides, Inc. is scheduled to begin clinical trials for NV-387, an oral drug designed to slow viral spread. These combined efforts target a high mortality rate in a volatile health environment.
What is confirmed
- Total confirmed Ebola cases in the Democratic Republic of Congo have exceeded 6,100.
- Deaths from the outbreak have surpassed 3,000.
- The crude fatality rate for the current outbreak is 48%.
- Merck previously distributed 16,000 doses of the Ervebo vaccine.
Still unconfirmed
- NanoViricides, Inc. will start clinical trials for the oral drug NV-387 next week.
What to watch next
- Results from the Saturday test vaccination program
- Commencement of NV-387 clinical trials
- Updated fatality and case counts from the DRC health ministry
confidence 90%Sources used for this update (9)
- jen.jiji.com — European Commission proposes EU KIDS Act to strengthen online safety of children
- jen.jiji.com — The CSR and Social Innovation Exhibition returns to Milan from 6 to 8 October
- jen.jiji.com — Heat dome brings record heat to south-central US in mid-September
- jen.jiji.com — Nepal flood death toll reaches 1,410, 6,145 still missing
- jen.jiji.com — We must work for improving our citizens' social well-being, not image — Tokayev
- jen.jiji.com — Tokayev tours Mynzhyldyk alley and GreenLine park in Astana
- jen.jiji.com — Egyptian archeologists unearth rare tombs, Roman camp in Nile Delta
- jen.jiji.com — Kazakhstan women beat Germany at FIDE Chess Olympiad
- medicalxpress.com — Ebola vaccine being tested in DR Congo outbreak zone
-
NanoViricides to begin Ebola oral drug trials in DR Congo next week
NanoViricides, Inc. will start clinical trials for the oral drug NV-387 next week to combat the expanding Ebola outbreak in the Democratic Republic of Congo. The initiative aims to lower the 48% crude fatality rate and slow the spread of the virus. This follows previous efforts including the distribution of 16,000 Ervebo vaccine doses from Merck and treatment support from the United States. The outbreak continues to expand, with total confirmed cases exceeding 6,100 and deaths surpassing 3,000.
Why it matters
The virus is spreading faster than current tracking and containment efforts can manage. The World Health Organization previously scheduled trials for three potential vaccines for this specific strain to begin by October or November.
What is confirmed
- NanoViricides, Inc. will start clinical trials for the oral drug NV-387 next week.
- The Ebola outbreak in the Democratic Republic of Congo has a 48% crude fatality rate.
- Confirmed Ebola cases have exceeded 6,100 with more than 3,000 deaths.
- Merck distributed over 16,000 Ervebo vaccine doses to address the outbreak.
What to watch next
- Results from the NV-387 clinical trials
- Start of the three WHO vaccine trials in October or November
- Official updates on the peak of the virus spread
confidence 100%Sources used for this update (10)
- jen.jiji.com — Kazakhstan and U.S. discuss ways to strengthen enhanced strategic partnership
- jen.jiji.com — Death toll from Nepal-China flash floods climbs to 1,420, at least 5,649 missing
- jen.jiji.com — Kazakhstan, Czech Republic join efforts in water infrastructure modernization
- jen.jiji.com — US Open, today Zverev-Khachanov: schedule, head-to-head and where to watch it on TV
- jen.jiji.com — Axios: Top secret meeting in Germany between US, Israel, and Arab commanders
- jen.jiji.com — Center-left poll, Conte beats Schlein in primaries
- www.usatoday.com — Clinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48 ...
- jen.jiji.com — Kazakhstan plans fourth oil refinery by 2033
- jen.jiji.com — Kazakhstan’s recoverable oil reserves estimated at 4.4 billion tons
- www.aljazeera.com — Ebola fight in DRC ‘far from over,’ warns WHO chief
-
Ebola outbreak in eastern Congo outpaces containment efforts
The Ebola outbreak in eastern Congo continues to spread faster than tracking and containment efforts can manage. The virus has likely not yet peaked, despite previous interventions including the distribution of over 16,000 Ervebo vaccine doses from Merck and treatment support from the United States. The World Health Organization has scheduled trials for three potential vaccines targeting this specific strain to begin by October or November. Total confirmed cases have exceeded 6,100, with more than 3,000 deaths reported.
Why it matters
Congo authorities are attempting to mitigate what is described as the fastest-growing outbreak in history. The situation remains critical as the speed of transmission exceeds the current capacity to isolate cases.
What is confirmed
- The Ebola outbreak in the Democratic Republic of Congo has killed more than 3,000 people.
- Confirmed Ebola cases in Congo now exceed 6,100.
- The World Health Organization scheduled trials for three potential vaccines for this strain to begin by October or November.
- Over 16,000 Ervebo vaccine doses from Merck were distributed to slow the spread.
Still unconfirmed
- The Ebola virus in eastern Congo has likely not yet peaked.
- The outbreak is spreading faster than efforts to track and contain it.
What to watch next
- The start of the three vaccine trials in October or November
- Updated case and death tolls from the World Health Organization
confidence 90%Sources used for this update (15)
- apnews.com — 5 challenges Congo faces in containing its fast-moving Ebola outbreak
- jen.jiji.com — Kazakhstan to create interactive map with history of geographic names
- jen.jiji.com — Kyrgyzstan to introduce mandatory tourist insurance
- jen.jiji.com — Tokayev signs decree defining powers of Kazakhstan’s Vice President
- jen.jiji.com — 35 Kazakh companies join China’s grain trading platform
- jen.jiji.com — Almaty oncology center introduces robotic pharmacy system
- jen.jiji.com — New exit and entry rules to come into force in China
- jen.jiji.com — Bishkek Arena stadium in Kyrgyzstan costs USD 386 million
- jen.jiji.com — Kazakhstan and Kyrgyzstan reaffirm commitment to allied relations
- medicalxpress.com — DRC's Ebola outbreak has the potential to become a global pandemic. How to make sure it doesn't
- jen.jiji.com — Almaty-London flight diverted to Frankfurt amid Heathrow closure
- www.usatoday.com — Ebola Oral Drug Trial NV-387 Registered in DRC for Outbreak
-
Congo Ebola deaths exceed 3,000 as WHO targets vaccine trials for October
The Ebola outbreak in the Democratic Republic of Congo has killed more than 3,000 people, with confirmed cases now exceeding 6,100. The World Health Organization announced Wednesday that trials for three potential vaccines targeting this specific strain are scheduled to begin by October or November. This follows previous efforts to slow the spread through the distribution of over 16,000 Ervebo vaccine doses from Merck and treatment support provided by the United States. Congo authorities previously began vaccinating citizens to mitigate the fastest-growing outbreak in history.
Why it matters
The scale of this outbreak is unprecedented, requiring international medical intervention to prevent further escalation. The transition to clinical trials for new vaccines indicates a shift toward finding a long-term solution for this specific strain. Ongoing government data tracking is essential for determining the efficacy of these medical interventions.
What is confirmed
- Congo's Ebola outbreak has killed more than 3,000 people.
- Confirmed Ebola cases in Congo have exceeded 6,100.
- The World Health Organization stated trials for three potential vaccines should begin by October or November.
What to watch next
- The official start date for the three vaccine trials in October or November
- Updated case and death tolls from the Congo government
confidence 100%Sources used for this update (6)
- jen.jiji.com — Egypt bus crash leaves 16 dead, 28 injured
- jen.jiji.com — Herd of Siberian ibex spotted in Ile-Alatau National Park
- apnews.com — Congo’s Ebola outbreak shows no signs of slowing as deaths top 3,000
- www.news9live.com — News headlines September 2, 2026: Nearly 12,000 rescued, 3,916 remain uncontactable: Nepal PM Shah
- jen.jiji.com — Kazakhstan moves ahead with construction of first nuclear power plant
- medicalxpress.com — DR Congo Ebola vaccine trials to begin by November: WHO
-
Congo Ebola Outbreak Surpasses 6,000 Cases
Congo authorities report that the fastest-growing Ebola outbreak in history has now exceeded 6,000 confirmed cases and 2,911 deaths. In response to the escalation, Congo began vaccinating citizens on Thursday to slow the spread of the disease. This effort follows previous shipments of over 16,000 doses of the Ervebo vaccine from Merck and treatment support provided by the United States.
Why it matters
The outbreak has already affected 60 health zones. It is currently the deadliest Ebola outbreak on record. Health officials are utilizing vaccinations and international aid to contain the virus.
What is confirmed
- Congo authorities report more than 6,000 confirmed Ebola cases and 2,911 deaths.
- Congo began vaccinating people against Ebola on Thursday.
- The current Ebola outbreak is the fastest-growing in history.
What to watch next
- Updates on vaccination coverage rates across the 60 affected health zones
- Reports on the efficacy of the current vaccination campaign in reducing new cases
confidence 100%Sources used for this update (6)
- jen.jiji.com — Kazakh equestrian claims silver at international tournament in Poland
- medicalxpress.com — Congo begins vaccinations to fight the fastest-growing Ebola outbreak in history
- jen.jiji.com — ADB approves $5 million emergency grant for Nepal flood relief
- apnews.com — Congo authorities report more than 6,000 confirmed Ebola cases and nearly 3,000 deaths
- jen.jiji.com — Kazakhstan, Saudi Arabia deepen transport and logistics cooperation
- jen.jiji.com — Kazinform News Agency and Albanian Telegraphic Agency open new communication channel
-
Congo's Ebola outbreak spreads as US provides treatment and vaccine doses
The Ebola outbreak in Congo has infected nearly 4,000 people and killed over 2,000, making it the deadliest outbreak in history. The US is providing Ebola treatment, and Congo has received over 16,000 doses of Merck's Ervebo vaccine. The outbreak has spread to 60 health zones, with over 300 deaths reported in the past week alone.
Why it matters
The Ebola outbreak in Congo is the fastest-growing in history, with a high number of cases and deaths reported in a short period. The disease has spread to multiple health zones, posing a significant challenge to health authorities. The international community, including the US, is providing support to combat the outbreak.
What is confirmed
- Congo has received more than 16,000 doses of the Ervebo vaccine.
- The Ebola outbreak in Congo has infected nearly 4,000 people and killed over 2,000.
- More than 300 people have died of Ebola in eastern Congo in the past week.
- The outbreak has spread to 60 health zones in eastern Congo.
What to watch next
- Further spread of the outbreak to new health zones
- Effectiveness of the US-provided Ebola treatment and Merck's Ervebo vaccine
- Congo government's response to the outbreak and containment efforts
confidence 100%Sources used for this update (8)
- abcnews.com — Congo receives more than 16,000 doses of Ebola vaccine amid unprecedented outbreak
- apnews.com — Congo’s Ebola outbreak records one of its highest weekly death tolls yet
- jen.jiji.com — 232 Kazakhstanis awarded Bolashak international scholarships
- san.com — A cancer vaccine breakthrough, medical AI faces a reality check and recalls pile up
- jen.jiji.com — Tokayev instructs drafting bills on AI, digital assets, and migration policy
- jen.jiji.com — Bronze Age settlement unearthed in N Kazakhstan
- apnews.com — Ebola outbreak in eastern Congo spreads to 2 new health zones with a total of 60 areas now affected
- apnews.com — Congo begins vaccinations to fight the fastest-growing Ebola outbreak in history
-
US provides Ebola treatment for Congo outbreak
The US is providing Ebola treatment for the outbreak in Congo, which is on track to surpass the deadliest outbreak in history. Congo will receive 70,000 doses of Merck's Ervebo Ebola vaccine, effective in past outbreaks. The outbreak has infected and killed more people at a greater speed than any other Ebola outbreak in history, with cases approaching 4,000 and at least 2,000 deaths.
Why it matters
The World Health Organization has warned that the crisis is on track to surpass the deadliest outbreak in history. The WHO chief has arrived in Congo to support ramped-up containment measures. Health officials are advancing talks to launch clinical trials for vaccines, starting with Merck's Ervebo and potentially including other candidates targeting the Bundibugyo species of the virus.
What is confirmed
- The Ebola outbreak in Congo has infected and killed more people at a greater speed than any other Ebola outbreak in history.
- Congo will receive 70,000 doses of Merck's Ervebo Ebola vaccine, which was effective in past outbreaks.
- The WHO said early laboratory and animal data suggest Ervebo may provide some protection against the Bundibugyo virus.
What to watch next
- The effectiveness of Ervebo against the Bundibugyo virus.
- The launch of clinical trials for vaccines.
- The impact of the outbreak on surrounding countries.
confidence 90%Sources used for this update (4)
- www.pbs.org — Congo to receive 70,000 doses of Ervebo Ebola vaccine, which was effective in past outbreaks
- www.inquirer.com — Congo to receive 70,000 doses of Ervebo Ebola vaccine, which has been effective in past outbreaks
- www.fbcnews.com.fj — Warning on addiction help amid funding uncertainty
- apnews.com — Here’s data that shows Congo’s Ebola outbreak is on track to surpass history’s largest
-
Congo Ebola deaths top 2,000 as WHO warns of record-breaking outbreak
Congo is facing the fastest-spreading Ebola outbreak on record, with at least 2,000 deaths and cases approaching 4,000. The World Health Organization warns the crisis is on track to surpass the deadliest outbreak in history. In response, the WHO chief has arrived in Congo to support ramped-up containment measures. Health officials are advancing talks to launch clinical trials for vaccines, starting with Merck's Ervebo and potentially including other candidates targeting the Bundibugyo species of the virus.
Why it matters
The current outbreak follows a period of rapid growth that previously saw over 3,400 cases. While Uganda recently declared itself free of the disease, the Congo situation is escalating in scale and lethality. The shift toward clinical trials indicates a move toward species-specific medical interventions.
What is confirmed
- At least 2,000 people have died among confirmed Ebola cases in Congo.
- The current Ebola outbreak in Congo is the fastest-spreading on record.
- The head of the World Health Organization has arrived in Congo to support response measures.
Still unconfirmed
- Other vaccines targeting the Bundibugyo species of Ebola could be added to trials.
What to watch next
- Updated case and death counts from the Congo government.
confidence 90%Sources used for this update (5)
- consent.yahoo.com — Treatment trials for Ebola strain behind Congo outbreak show promise, WHO says
- apnews.com — WHO chief arrives in Congo to support Ebola response as cases near 4,000
- www.cbsnews.com — Congo Ebola death toll tops 2,000 as outbreak becomes fastest spreading on record
- www.latimes.com — WHO says Congo’s Ebola outbreak is on track to eclipse the deadliest one in history
- www.statnews.com — Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says
-
Congo Ebola death toll exceeds 1,500 as Uganda declares virus free
Congo continues to battle a rapid Ebola outbreak with over 3,400 recorded cases. Uganda has officially declared itself free of the disease following the discharge of its final patient. The Africa Centers for Disease Control and Prevention attributes a recent spike in numbers to a backlog of records.
What's confirmed:
- Uganda declared itself free of Ebola on Tuesday.
- The last Ebola patient in Uganda was discharged in mid-June.
- Congo has recorded 3,442 cases and 1,521 deaths as of Tuesday.
confidence 100%Sources used for this update (2)
-
Ebola cases in eastern Congo surpass 3,200
The Ebola outbreak in eastern Congo has exceeded 3,200 cases. This surge nearly matches the totals from the 2018-2020 outbreak in just 10 weeks. Uganda has declared itself free of the disease.
What's confirmed:
- The Ebola outbreak in eastern Congo has surpassed 3,200 cases.
- The outbreak in Congo is nearing record-high case numbers.
Still unconfirmed:
- The current outbreak has nearly matched the 2018-2020 outbreak in 10 weeks.
- Uganda is Ebola free.
confidence 90%Sources used for this update (2)
-
Ebola Treatment Trials Begin in Democratic Republic of Congo
Researchers started a study on Thursday to test two potential Ebola treatments in eastern Congo. The effort aims to improve survival rates as the outbreak grows. The World Health Organization is overseeing the clinical testing of these antiviral therapies.
What's confirmed:
- Researchers began a study of two possible Ebola treatments on Thursday in eastern Congo.
- The World Health Organization announced the start of clinical testing for two antiviral therapy approaches.
- There are 438 deaths linked to the outbreak.
Still unconfirmed:
- The Bundibugyo virus caused over 1,400 infections.
- There are 1,406 confirmed cases and 301 suspected cases of the disease in DRC.
confidence 90%Sources used for this update (5)
- Researchers launch study on Ebola treatments as Congo outbreak worsens
- WHO says two Ebola treatments begin clinical trials in Congo
- Researchers launch study on Ebola treatments as Congo outbreak worsens
- Researchers launch study on Ebola treatments as Congo outbreak worsens
- Ebola treatments trial begins in the Democratic Republic of Congo - BBC
-
US Provides Experimental Ebola Treatment for Congo Outbreak Trials
The United States has supplied doses of an experimental antibody drug from Mapp Biopharmaceutical for clinical trials in the Democratic Republic of Congo. This move supports efforts to combat a widening Ebola outbreak. The WHO indicates that trials for two drugs are scheduled to begin next week.
What's confirmed:
- The US provided doses of an experimental antibody drug from Mapp Biopharmaceutical for clinical trials in the Democratic Republic of Congo.
- The US previously stated the antibody drug would be available only to Americans deemed to be at high risk.
- HHS sent the drug for the Ebola clinical trial.
- The WHO chief stated that antivirals from Mapp and Gilead will be deployed in the DRC Ebola trial.
Still unconfirmed:
- The Ebola outbreak in the Democratic Republic of Congo has caused more than 1,000 deaths.
- Trials of two Ebola treatments will start in the DRC next week.
confidence 95%Sources used for this update (12)
- US provides Ebola treatment for outbreak in Congo, bringing trials closer
- Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief
- Clinical trial set to test two drugs for fast-growing Ebola outbreak
- U.S. provides experimental Ebola treatment for outbreak in Congo, bringing trials closer
- Trials of two Ebola treatments to start in DRC next week: WHO
- HHS has sent drug for Ebola clinical trial
- US provides Ebola treatment for outbreak in Congo, bringing ... - Yahoo
- US provides Ebola treatment for outbreak in Congo, bringing trials ...
- U.S. provides experimental Ebola treatment for outbreak in Congo
- US provides Ebola treatment for outbreak in Congo, bringing trials ...
- US releases experimental Ebola drug for DR Congo outbreak trials
- FOCUS-US provides Ebola treatment for outbreak in Congo, bringing ...
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community